Wells Fargo
APLT

Wells Fargo’s Applied Therapeutics APLT Stock Holding History

Wells Fargo’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,494
Closed -$776 – 7083
2025
Q2 		$776 Sell
2,494
-49,014
-95% -$19K ﹤0.01% 6334
2025
Q1 		$25.2K Buy
51,508
+2,051
+4% +$1.21K ﹤0.01% 5630
2024
Q4 		$42.3K Buy
49,457
+13,721
+38% +$86K ﹤0.01% 5543
2024
Q3 		$304K Buy
35,736
+440
+1% +$2.59K ﹤0.01% 4305
2024
Q2 		$165K Buy
35,296
+34,861
+8,014% +$165K ﹤0.01% 4639
2024
Q1 		$2.96K Buy
435
+7
+2% +$31 ﹤0.01% 5970
2023
Q4 		$1.43K Sell
428
-76
-15% -$189 ﹤0.01% 6149
2023
Q3 		$1.25K Buy
504
+162
+47% +$267 ﹤0.01% 6164
2023
Q2 		$438 Buy
342
+69
+25% +$92 ﹤0.01% 6517
2023
Q1 		$221 Buy
273
+5
+2% +$5 ﹤0.01% 6747
2022
Q4 		$204 Buy
268
+7
+3% +$6 ﹤0.01% 6618
2022
Q3 		$0 Buy
261
+142
+119% +$170 ﹤0.01% 6622
2022
Q2 		$0 Sell
119
-1,346
-92% -$2.2K ﹤0.01% 6760
2022
Q1 		$3K Sell
1,465
-6,255
-81% -$16.8K ﹤0.01% 6565
2021
Q4 		$69K Buy
7,720
+7,718
+385,900% +$101K ﹤0.01% 5813
2021
Q3 		$0 Hold
2
– – ﹤0.01% 6937
2021
Q2 		$0 Sell
2
-2,409
-100% -$45.6K ﹤0.01% 6874
2021
Q1 		$45K Sell
2,411
-7,374
-75% -$159K ﹤0.01% 5855
2020
Q4 		$215K Buy
9,785
+337
+4% +$7.02K ﹤0.01% 5043
2020
Q3 		$196K Sell
9,448
-2,486
-21% -$64.6K ﹤0.01% 4974
2020
Q2 		$432K Buy
11,934
+6,657
+126% +$279K ﹤0.01% 4431
2020
Q1 		$172K Buy
5,277
+1,553
+42% +$62.8K ﹤0.01% 4768
2019
Q4 		$102K Buy
3,724
+3,562
+2,199% +$61K ﹤0.01% 5286
2019
Q3 		$2K Buy
+162
New +$1.53K ﹤0.01% 6174

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Wells Fargo's APLT Position: Q3 2025 in Review

Wells Fargo sold out of Applied Therapeutics (APLT) in Q3 2025, closing a stake of 2,494 shares — an estimated $776 sold.

Wells Fargo first reported a position in APLT in Q3 2019 and held it in 24 quarters. The position peaked at $432K in Q2 2020. 70 funds tracked by Wall St. Rank hold APLT as of Q3 2025.

  • Wells Fargo reported no remaining Applied Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Wells Fargo sold 2,494 Applied Therapeutics shares in Q3 2025, an estimated $776.
  • Wells Fargo first reported a position in Applied Therapeutics in Q3 2019 and held it in 24 quarters.
  • Wells Fargo's Applied Therapeutics position peaked at $432K in Q2 2020.
  • 70 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2025.

Based on Wells Fargo's 13F filing for Q3 2025, filed 13 Nov 2025.